| Application no. and date | 18177227.8 (espacenet) (Federated) (European Patent Register), 20090625 | | Patent/reg. no. and date | DK/EP 3444274, 20201223 | | Publication date | 20190220 | | Priority no. and date | US 75640 P, 20080625, US 75692 P, 20080625, US 75697 P, 20080625, US 75956 P, 20080626, US 155041 P, 20090224 | | EP pub. no. and date |
EP 3444274 20190220 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/163718 | | Inventor | GUNDE, Tea, Ottostrasse 15
8005 Zürich, CH,
BORRAS, Leonardo, Bundentalstrasse 1
8952 Schlieren, CH,
Urech, David, Sonnenblickstrasse 8
8645 Jona, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/24 (2006.01) , C12N 15/13 (2006.01) | | Title | Stabile og opløselige antistoffer, der hæmmer TNF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
